Table 5.
In vivo findings of baicalein, baicalin, and wogonin on different animal models.
Models | Species | Baicalein | Baicalin | Wogonin | References | |||
---|---|---|---|---|---|---|---|---|
Conc. | Effects | Conc. | Effects | Conc. | Effects | |||
I/R | Rat | 0.5 nmol | Effectively protect retinal cells and electrical functions from oxidation and apoptosis; upregulation of HO-1 and downregulation of HIF-1α, VEGF, and MMP-1 | 12.5 mg/kg | Protect RGCs from retinal ischemia injury and suppress glial cell activity | [123, 128] | ||
DR | Rat; mice | 150 mg/kg in rat; 75 mg/kg in mice | Significantly suppressed the inflammatory processes of retinal microglia and Muller cells; enhanced vascular permeability and blood-retina barrier; protect BRB permeability as antioxidant 12/15-LOX inhibitor, anti-inflammation, and antiangiogenesis | 150 mg/ml in rat | Protect retinal cells from apoptosis by promoting Bcl-2; perform as an inhibitor of ARA and delay the progression of diabetic retinopathy | [130, 131] |